Jan 30, 2020 | 340B, Litigation, News and Updates
After the Health and Resource Service Administration (HRSA) issued a December Advisory Opinion requiring 340B discounts for drugs dispensed through contract pharmacies, four drug manufacturers—Eli Lilly, AstraZeneca, Sanofi, and Novo Nordisk—have now filed four...
Dec 2, 2019 | Litigation, Medicaid, News and Updates
On December 2, 2019, the Texas Health and Human Services Commission filed suit against HHS seeking reversal of an August 2018 DAB decision that upheld a $25 million disallowance against the state. The complaint, filed in D.C District Court, argues that the standard...
Oct 11, 2019 | Litigation, Medicaid, News and Updates
Federal district courts in Washington, New York, and California have blocked the Trump Administration’s public charge rule from going into effect. The Southern District of New York’s ruling applies on a nationwide basis, with the other two rulings limited...
Sep 18, 2019 | Litigation, Medicare, News and Updates
On September 18, 2019, the D.C. District Court ruled that CMS exceeded its authority when it extended site-neutral payment to certain services in grandfathered clinics. The policy, issued as part of the November 2018 Outpatient Prospective Payment System (OPPS) Final...
Sep 13, 2019 | DSH, Litigation, Medicaid, News and Updates
Over the last several years, courts in various jurisdictions have issued rulings in lawsuits challenging the Centers for Medicare & Medicaid Services’ (CMS’) policy requiring the inclusion of Medicare and commercial payments in the calculation of the Medicaid...
Aug 13, 2019 | DSH, Litigation, News and Updates
On August 13, 2019, the D.C. Circuit issued its highly-anticipated decision in a lawsuit brought by the Children’s Hospital Association of Texas (CHAT) and others, challenging the legality of CMS’ 2017 Medicaid DSH third-party payer final rule that was set to take...
